Lamivudine 50742-0623-60

Package NDC

50742-0623-60

Manufacturer: Ingenus Pharmaceuticals, Llc
Dosage Form: Tablet
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: February 1, 2017
Listing Expires: December 31, 2026
Application: ANDA206974

Need to source Lamivudine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Lamivudine	150 mg/1

Drug Class

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

Selected Package

50742-0623-60Selected

60 TABLET in 1 BOTTLE, PLASTIC (50742-623-60)